2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain

Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., Waku, K.·1995·Biochemical and Biophysical Research Communications

Cited by (1,009)

Items 801–900 of 1,009

  1. Endocannabinoid regulation of β ‐cell functions: implications for glycaemic control and diabetes
    Tony Jourdan, Grzegorz Godlewski, George Kunos · 2016 · Diabetes Obesity and Metabolism
  2. The endocannabinoid system in cardiovascular function: novel insights and clinical implications
    Salvador Sierra, Natasha Luquin, Judith Navarro‐Otano · 2017 · Clinical Autonomic Research
  3. Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid.
    Krista Laine, Kristiina Järvinen, Raphael Mechoulam, Aviva Breuer, Tomi Järvinen · 2002 · PubMed
  4. Endocannabinoid signaling in the central nervous system
    César E. Martinez Ramirez, Gonzalo Ruiz‐Pérez, Todd M. Stollenwerk, Christina Behlke, Ashley Doherty, Cecilia J. Hillard · 2022 · Glia
  5. The role of dopamine and endocannabinoid systems in prefrontal cortex development: Adolescence as a critical period
    Kate Zara Peters, Fabien Naneix · 2022 · Frontiers in Neural Circuits
  6. Orphan endogenous lipids and orphan GPCRs: A good match
    Heather B. Bradshaw, Sung Ha Lee, Douglas McHugh · 2009 · Prostaglandins & Other Lipid Mediators
  7. N -Arachidonoyl- l -Serine is Neuroprotective after Traumatic Brain Injury by Reducing Apoptosis
    Ayelet Cohen‐Yeshurun, Victoria Trembovler, Alexander G. Alexandrovich, Erik Ryberg, Peter J. Greasley, Raphael Mechoulam, Esther Shohami, Ronen R. Leker · 2011 · Journal of Cerebral Blood Flow & Metabolism
  8. Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives
    María Scherma, Anna Lisa Muntoni, Miriam Melis, Liana Fattore, Paola Fadda, Walter Fratta, Marco Pistis · 2016 · Psychopharmacology
  9. Clinical studies and anti‐inflammatory mechanisms of treatments
    Jacqueline A. French, Matthias J. Koepp, Yvonne Naegelin, Federico Vigevano, Stéphane Auvin, Jong M. Rho, Evan C. Rosenberg, Orrin Devinsky, Peder S. Olofsson, Marc A. Dichter · 2017 · Epilepsia
  10. Alterations in behavioral flexibility by cannabinoid CB1 receptor agonists and antagonists
    Matthew N. Hill, Larissa M. Froese, Anna C. Morrish, Jane C. Sun, Stan Floresco · 2006 · Psychopharmacology
  11. Ibuprofen Inhibits the Metabolism of the Endogenous Cannabimimetic Agent Anandamide
    Christopher John Fowler, Anders Stenström, Gunnar Tiger · 1997 · Pharmacology & Toxicology
  12. The pseudokinase tribbles homologue-3 plays a crucial role in cannabinoid anticancer action
    María Salazar‐Roa, Mar Lorente, Elena García-Taboada, Sonia Hernández‐Tiedra, David Dávila, Sheila Francis, Manuel Guzmán, Endre Kiss‐Toth, Guillermo Velasco · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  13. Müller cells express the cannabinoid CB2 receptor in the vervet monkey retina
    Joseph Bouskila, Pasha Javadi, Christian Casanova, Maurice Ptito, Jean‐François Bouchard · 2013 · The Journal of Comparative Neurology
  14. Cannabinoid receptor type 1 antagonism significantly modulates basal and loud noise induced neural and hypothalamic–pituitary–adrenal axis responses in male Sprague–Dawley rats
    Newsom, R.J., Osterlund, C., Masini, C.V., Day, H.E., Spencer, R.L., Campeau, S. · 2012 · Neuroscience
  15. Endocannabinoid signaling in hypothalamic–pituitary–adrenocortical axis recovery following stress: Effects of indirect agonists and comparison of male and female mice
    Christopher J. Roberts, Kara L. Stuhr, Michael J. Hutz, Hershel Raff, Cecilia J. Hillard · 2013 · Pharmacology Biochemistry and Behavior
  16. Determination of the two major endocannabinoids in human plasma by μ-SPE followed by HPLC-MS/MS
    Manuel Sergi, Natalia Battista, Camilla Montesano, Roberta Curini, Mauro Maccarrone, Darío Compagnone · 2012 · Analytical and Bioanalytical Chemistry
  17. Endocannabinoids and Nutrition
    Harald Severin Hansen, Andreas Artmann · 2008 · Journal of Neuroendocrinology
  18. The endocannabinoid system: Its roles in energy balance and potential as a target for obesity treatment
    Aurore André, Marie‐Paule Gonthier · 2010 · The International Journal of Biochemistry & Cell Biology
  19. Prostaglandin F2α Formation from Prostaglandin H2 by Prostaglandin F Synthase (PGFS): Crystal Structure of PGFS Containing Bimatoprost,
    Junichi Komoto, Taro Yamada, Kikuko Watanabe, David F. Woodward, Fusao Takusagawa · 2006 · Biochemistry
  20. Full Fatty Acid Amide Hydrolase Inhibition Combined with Partial Monoacylglycerol Lipase Inhibition: Augmented and Sustained Antinociceptive Effects with Reduced Cannabimimetic Side Effects in Mice
    Ghosh, Sudeshna, Kinsey, Steven G., Liu, Qing-song, Hruba, Lenka, McMahon, Lance R., Grim, Travis W., Merritt, Christina R., Wise, Laura E., Abdullah, Rehab A., Selley, Dana E. et al. · 2015 · The Journal of Pharmacology and Experimental Therapeutics
  21. Diacylglycerol lipase β inhibition reverses nociceptive behaviour in mouse models of inflammatory and neuropathic pain
    Jenny L. Wilkerson, Sudeshna Ghosh, Deniz Bağdaş, B L Mason, Molly S. Crowe, Ku‐Lung Hsu, Laura E. Wise, Steven G. Kinsey, Mohamad Imad Damaj, Benjamin F. Cravatt et al. · 2016 · British Journal of Pharmacology
  22. Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward Regions
    Natalie E. Zlebnik, Joseph F. Cheer · 2016 · Journal of Neuroscience
  23. Targeting the endocannabinoid system as a potential anticancer approach
    Rico Schwarz, Robert Ramer, Burkhard Hinz · 2018 · Drug Metabolism Reviews
  24. Negative Regulation of Leptin-induced Reactive Oxygen Species (ROS) Formation by Cannabinoid CB1 Receptor Activation in Hypothalamic Neurons
    Letizia Palomba, Cristoforo Silvestri, Roberta Imperatore, Giovanna Morello, Fabiana Piscitelli, Andrea Martella, Luigia Cristino, Vincenzo Di Marzo · 2015 · Journal of Biological Chemistry
  25. 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces rapid actin polymerization in HL-60 cells differentiated into macrophage-like cells
    Maiko Gokoh, Seishi Kishimoto, Saori Oka, Masahiro Mori, Keizo Waku, Yoshio Ishima, Takayuki Sugiura · 2005 · Biochemical Journal
  26. Endocannabinoid Signaling in Midbrain Dopamine Neurons: More than Physiology?
    Miriam Melis, Marco Pistis · 2007 · Current Neuropharmacology
  27. Synapse type-independent degradation of the endocannabinoid 2-arachidonoylglycerol after retrograde synaptic suppression
    Asami Tanimura, Motokazu Uchigashima, Maya Yamazaki, Naofumi Uesaka, Takayasu Mikuni, Manabu Abe, Kouichi Hashimoto, Masahiko Watanabe, Kenji Sakimura, Masanobu Kano · 2012 · Proceedings of the National Academy of Sciences
  28. Clinical Pharmacokinetics of Cannabinoids
    Franjo Grotenhermen · 2003 · Journal of Cannabis Therapeutics
  29. Screening of Various Hormone‐Sensitive Lipase Inhibitors as Endocannabinoid‐Hydrolyzing Enzyme Inhibitors
    Anna Minkkilä, Juha R. Savinainen, Heikki Käsnänen, Henri Xhaard, Tapio Nevalainen, Jarmo T. Laitinen, Antti Poso, Jukka Leppänen, Susanna M. Saario · 2009 · ChemMedChem
  30. Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings
    Andrew J. Kesner, David M. Lovinger · 2021 · Journal of Neurochemistry
  31. Diverse roles of 2‐arachidonoylglycerol in invasion of prostate carcinoma cells: Location, hydrolysis and 12‐lipoxygenase metabolism
    Michael P. Endsley, Nitin T. Aggarwal, Marilyn A. Isbell, Craig E. Wheelock, Bruce D. Hammock, John Russell Falck, William B. Campbell, Kasem Nithipatikom · 2007 · International Journal of Cancer
  32. The Application of 3D-QSAR Studies for Novel Cannabinoid Ligands Substituted at the C1‘ Position of the Alkyl Side Chain on the Structural Requirements for Binding to Cannabinoid Receptors CB1 and CB2
    Serdar Durdağı, Agnes Kapou, Therapia Kourouli, Thanos Andreou, Spyros P. Nikas, Victoria R. Nahmias, Demetris P. Papahatjis, Μάνθος Γ. Παπαδόπουλος, Thomas Mavromoustakos · 2007 · Journal of Medicinal Chemistry
  33. Novel Natural and Synthetic Ligands of the Endocannabinoid System
    Lumir Ondrej Hanus, Raphael Mechoulam · 2010 · Current Medicinal Chemistry
  34. Rimonabant Redux and Strategies to Improve the Future Outlook of CB1 Receptor Neutral‐Antagonist/Inverse‐Agonist Therapies
    Sara Jane Ward, Robert B. Raffa · 2011 · Obesity
  35. Activation of cannabinoid receptor CB2 regulates osteogenic and osteoclastogenic gene expression in human periodontal ligament cells
    Hong Qian, Yimin Zhao, Yong Peng, C. Han, S. Li, Na Huo, Y. Ding, Y. Duan, L. Xiong, H. Sang · 2010 · Journal of Periodontal Research
  36. Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy
    Lara Senn, Giuseppe Cannazza, Giuseppe Biagini · 2020 · Pharmaceuticals
  37. Pharmacophoric Requirements for the Cannabinoid Side Chain. Probing the Cannabinoid Receptor Subsite at C1‘
    Demetris P. Papahatjis, Spyros P. Nikas, Therapia Kourouli · 2003 · Journal of Medicinal Chemistry
  38. Cannabinoid receptors as therapeutic targets for obesity and metabolic diseases
    Luigi Bellocchio, G MANCINI, Valentina Vicennati, Riccardo Pasquali, Uberto Pagotto · 2006 · Current Opinion in Pharmacology
  39. Function and therapeutic potential of N-acyl amino acids
    Sukanya Arul Prakash, Ravi Kanth Kamlekar · 2021 · Chemistry and Physics of Lipids
  40. Post‐ischemic brain damage: the endocannabinoid system in the mechanisms of neuronal death
    Domenico Edoardo Pellegrini-Giampietro, Guido Mannaioni, Giacinto Bagetta · 2008 · FEBS Journal
  41. Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists
    Andrea Behrenswerth, N. Volz, J. Toräng, Sonja Hinz, Stefan Bräse, Christa Elisabeth Müller · 2009 · Bioorganic & Medicinal Chemistry
  42. Low level chlorpyrifos exposure increases anandamide accumulation in juvenile rat brain in the absence of brain cholinesterase inhibition
    Russell L. Carr, Casey A. Graves, Lee C. Mangum, Carole A. Nail, Matthew K. Ross · 2013 · NeuroToxicology
  43. The endocannabinoid anandamide induces apoptosis of rat decidual cells through a mechanism involving ceramide synthesis and p38 MAPK activation
    Bruno Miguel Fonseca, Georgina Correia‐da‐Silva, Natércia A. A. Teixeira · 2013 · APOPTOSIS
  44. The Endocannabinoid System: Current Pharmacological Research and Therapeutic Possibilities
    Kent‐Olov Jonsson, Sandra Holt, Christopher John Fowler · 2006 · Basic & Clinical Pharmacology & Toxicology
  45. Broad impact of deleting endogenous cannabinoid hydrolyzing enzymes and the CB1 cannabinoid receptor on the endogenous cannabinoid-related lipidome in eight regions of the mouse brain
    Emma Leishman, Ben Cornett, Karl Spork, Alex J. Straiker, Ken Mackie, Heather B. Bradshaw · 2016 · Pharmacological Research
  46. Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide)
    Erin C. Hanlon · 2019 · Psychoneuroendocrinology
  47. Targeting the Endocannabinoid System in Alzheimer's Disease
    Jeremy L. Koppel, Peter Davies · 2008 · Journal of Alzheimer s Disease
  48. C1‘-Cycloalkyl Side Chain Pharmacophore in Tetrahydrocannabinols
    Demetris P. Papahatjis, Victoria R. Nahmias, Spyros P. Nikas, Thanos Andreou, Shakiru O. Alapafuja, Andrew Tsotinis, Jianxin Guo, Pusheng Fan, Alexandros Makriyannis · 2007 · Journal of Medicinal Chemistry
  49. A possible role for the endocannabinoid system in the neurobiology of depression
    Gino Serra, Walter Fratta · 2007 · Clinical Practice and Epidemiology in Mental Health
  50. Spatio-temporal expression patterns of anandamide-binding receptors in rat implantation sites: evidence for a role of the endocannabinoid system during the period of placental development
    Bruno Miguel Fonseca, Georgina Correia‐da‐Silva, Anthony Henry Taylor · 2009 · Reproductive Biology and Endocrinology
  51. Immune control by endocannabinoids — New mechanisms of neuroprotection?
    Oliver Ullrich, Katrin Merker, Johanna Timm, Svantje Tauber · 2006 · Journal of Neuroimmunology
  52. Minireview: From the Bench, Toward the Clinic: Therapeutic Opportunities for Cannabinoid Receptor Modulation
    Robert P. Picone, Debra A. Kendall · 2015 · Molecular Endocrinology
  53. Cannabinoid signalling regulates inflammation and energy balance: The importance of the brain–gut axis
    Nina L. Cluny, Raylene A. Reimer, Keith A. Sharkey · 2012 · Brain Behavior and Immunity
  54. Synthesis and Pharmacological Activity of a Potent Inhibitor of the Biosynthesis of the Endocannabinoid 2‐Arachidonoylglycerol
    Tiziana Bisogno, James J. Burston, Ravi Rai, Marco Allarà, Bijali Saha, Anu Mahadevan, Raj K. Razdan, Jenny L. Wiley, Vincenzo Di Marzo · 2009 · ChemMedChem
  55. The central cannabinoid receptor type-2 (CB2) and chronic pain
    Yu-chao Shang, Yuying Tang · 2016 · International Journal of Neuroscience
  56. Endocannabinoid‐related compounds in gastrointestinal diseases
    Marcella Pesce, Alessandra D’Alessandro, Osvaldo Borrelli, Stefano Gigli, Luisa Seguella, Rosario Cuomo, Giuseppe Esposito, Giovanni Sarnelli · 2017 · Journal of Cellular and Molecular Medicine
  57. N-Oleoyl-glycine reduces nicotine reward and withdrawal in mice
    Giulia Donvito, Fabiana Piscitelli, Pretal P. Muldoon, Asti B. Jackson, Rosa Maria Vitale, Enrico D’Aniello, Catia Giordano, Bogna Marta Ignatowska-Jankowska, Mohammed Ahmed Mustafa, Francesca Guida et al. · 2018 · Neuropharmacology
  58. CYP2J2 Molecular Recognition: A New Axis for Therapeutic Design
    Aditi Das, Austin T. Weigle, William R. Arnold, Justin S. Kim, Lauren N. Carnevale, Hannah C. Huff · 2020 · Pharmacology & Therapeutics
  59. Calcium signaling and synaptic modulation: Regulation of endocannabinoid-mediated synaptic modulation by calcium
    Takako Ohno‐Shosaku, Yuki Hashimotodani, Takashi Maejima, Masanobu Kano · 2005 · Cell Calcium
  60. Anandamide amidohydrolase of porcine brain: cDNA cloning, functional expression and site-directed mutagenesis
    Sravan Kumar Goparaju, Yuko Kurahashi, Hiroshi Suzuki, Natsuo Ueda, Shozo Yamamoto · 1999 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  61. Endocannabinoid signaling mechanisms in the substantia nigra pars reticulata modulate GABAergic nigrotectal pathways in mice threatened by urutu-cruzeiro venomous pit viper
    Rafael Carvalho Almada, Camila Marroni Roncon, Daoud Hibraim Elias-Filho, Norberto Cysne Coimbra · 2015 · Neuroscience
  62. Fetal Alcohol Spectrum Disorder: Potential Role of Endocannabinoids Signaling
    Balapal S. Basavarajappa · 2015 · Brain Sciences
  63. DAG Lipase Involvement in Depolarization-Induced Suppression of Inhibition: Does Endocannabinoid Biosynthesis Always Meet the Demand?
    Rogier Min, Vincenzo Di Marzo, Huibert D. Mansvelder · 2010 · The Neuroscientist
  64. The Pharmacological History of Cannabis
    Ethan B. Russo · 2014 · Oxford University Press eBooks
  65. The quest for a vascular endothelial cannabinoid receptor
    George Kunos, Sándor Bátkai, László Offertáler, Fanny Mo, Jie Liu, Jan C. Karcher, Judith Dale Harvey-White · 2002 · Chemistry and Physics of Lipids
  66. The Cannabinoid 1 Receptor Antagonist, AM251, Prolongs the Survival of Rats with Severe Acute Pancreatitis
    Kazuhisa Matsuda, Yukio Mikami, Kazunori Takeda, Shoji Fukuyama, Shinichi Egawa, Makoto Sunamura, Ikurou Maruyama, Seiki Matsuno · 2005 · The Tohoku Journal of Experimental Medicine
  67. An optimized GC–MS method detects nanomolar amounts of anandamide in mouse brain
    Giulio G. Muccioli, Nephi Stella · 2007 · Analytical Biochemistry
  68. Structural and functional differences between cyclooxygenases: Fatty acid oxygenases with a critical role in cell signaling
    Carol A. Rouzer, Lawrence J. Marnett · 2005 · Biochemical and Biophysical Research Communications
  69. Cannabis and endocannabinoid modulators: Therapeutic promises and challenges
    Igor Grant, B. Rael Cahn · 2005 · Clinical Neuroscience Research
  70. Cannabinoid agonists and antagonists modulate lithium-induced conditioned gaping in rats
    Linda A. Parker, Raphael Mechoulam · 2003 · Integrative Psychological and Behavioral Science
  71. Cannabis and Cannabinoids in Reproduction and Fertility: Where We Stand
    Bruno Miguel Fonseca, Irene Rebelo · 2021 · Reproductive Sciences
  72. Cannabinoid Receptor 1 Signaling in Embryo Neurodevelopment
    Delphine Psychoyos, K. Yaragudri Vinod, Jin Cao, Shan Xie, Richard L. Hyson, Bogdan J. Wlodarczyk, Weimin He, Thomas B. Cooper, Basalingappa L. Hungund, Richard H. Finnell · 2012 · Birth Defects Research Part B Developmental and Reproductive Toxicology
  73. Review article: the endocannabinoid system in liver disease, a potential therapeutic target
    Patrick P Basu, Mark M. Aloysius, Niraj James Shah, Robert S. Brown · 2014 · Alimentary Pharmacology & Therapeutics
  74. Early maternal deprivation induces changes on the expression of 2-AG biosynthesis and degradation enzymes in neonatal rat hippocampus
    Juan Suárez, Patricia Rivera, Ricardo Llorente, Silvana‐Yanina Romero‐Zerbo, Francisco Javier Bermúdez‐Silva, Fernando Rodrı́guez de Fonseca, María‐Paz Viveros · 2010 · Brain Research
  75. Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New Targets for Future Antidepressants
    Shintaro Ogawa, Hiroshi Kunugi · 2015 · Current Neuropharmacology
  76. Study of sample preparation for determination of endocannabinoids and analogous compounds in human serum by LC–MS/MS in MRM mode
    Diego Luque-Córdoba, M. Calderón-Santiago, M. D. Luque de Castro, Feliciano Priego‐Capote · 2018 · Talanta
  77. Cannabinoids in the descending pain modulatory circuit: Role in inflammation
    Courtney A. Bouchet, Susan Ingram · 2020 · Pharmacology & Therapeutics
  78. Cannabinoids in Breast Cancer: Differential Susceptibility According to Subtype
    Cristina Ferreira Almeida, Natércia A. A. Teixeira, Georgina Correia‐da‐Silva, Cristina Amaral · 2021 · Molecules
  79. Combination of Rimonabant and Donepezil Prolongs Spatial Memory Duration
    Laura E. Wise, Philip A. Iredale, Rene J. Stokes, Aron H. Lichtman · 2007 · Neuropsychopharmacology
  80. Cannabinoids and neuronal damage: Differential effects of THC, AEA and 2-AG on activated microglial cells and degenerating neurons in excitotoxically lesioned rat organotypic hippocampal slice cultures
    Susanne Kreutz, Marco Koch, Chalid Ghadban, Horst‐Werner Korf, Faramarz Dehghani · 2006 · Experimental Neurology
  81. A new class of inhibitors of 2-arachidonoylglycerol hydrolysis and invasion of prostate cancer cells
    Kasem Nithipatikom, Michael P. Endsley, Marilyn A. Isbell, Craig E. Wheelock, Bruce D. Hammock, William B. Campbell · 2005 · Biochemical and Biophysical Research Communications
  82. Synthesis and Activity of 1,3,5-Triphenylimidazolidine-2,4-diones and 1,3,5-Triphenyl-2-thioxoimidazolidin-4-ones: Characterization of New CB1 Cannabinoid Receptor Inverse Agonists/Antagonists
    Giulio G. Muccioli, Johan Wouters, Caroline Charlier · 2006 · Journal of Medicinal Chemistry
  83. Lack of association of genetic variants in genes of the endocannabinoid system with anorexia nervosa
    Timo D. Müller, Kathrin Reichwald, Günter Brönner, Jeanette Kirschner, Thuy Trang Nguyen, André Scherag, Wolfgang Herzog, Beate Herpertz‐Dahlmann, Peter Lichtner, Thomas Meitinger et al. · 2008 · Child and Adolescent Psychiatry and Mental Health
  84. Effects of anandamide on embryo implantation in the mouse
    W.M Liu, Enkui Duan, Y.J Cao · 2002 · Life Sciences
  85. Endocannabinoid signaling in synchronizing embryo development and uterine receptivity for implantation.
    Paria, B.C., Wang, H., Dey, S.K. · 2002 · Chemistry and Physics of Lipids
  86. Cannabidiol for the treatment of autism spectrum disorder: hope or hype?
    João Francisco Cordeiro Pedrazzi, Frederico Rogério Ferreira, Danyelle Silva-Amaral, Daniel de Alencar Lima, Jaime E. C. Hallak, Antônio Waldo Zuardi, Elaine Aparecida Del Bel, Francisco Silveira Guimarães, Karla Cristinne Mancini Costa, Alline Cristina Campos et al. · 2022 · Psychopharmacology
  87. Cannabinoid treatments in epilepsy and seizure disorders
    Orrin Devinsky, Nicholas A. Jones, Mark O. Cunningham, Bodiabaduge A. P. Jayasekera, Sasha Devore, Benjamin J. Whalley · 2023 · Physiological Reviews
  88. Cannabinoids Biology: The Search for New Therapeutic Targets
    Christian C. Felder · 2006 · Molecular Interventions
  89. The Endocannabinoid System in the Postimplantation Period: A Role during Decidualization and Placentation
    Bruno Miguel Fonseca, Georgina Correia‐da‐Silva, Marta Almada · 2013 · International Journal of Endocrinology
  90. G protein-coupled receptors as oncogenic signals in glioma: Emerging therapeutic avenues
    Allison E. Cherry, Nephi Stella · 2014 · Neuroscience
  91. Endocannabinoid system: Potential novel targets for treatment of schizophrenia
    Atsushi Saito, Michael D. Ballinger, Mikhail V. Pletnikov, Dean Foster Wong, Atsushi Kamiya · 2012 · Neurobiology of Disease
  92. Biosynthesis and Fate of Endocannabinoids
    Maria Grazia Cascio, Pietro Marini · 2015 · Handbook of experimental pharmacology
  93. Driving the need to feed: Insight into the collaborative interaction between ghrelin and endocannabinoid systems in modulating brain reward systems
    Alexander Edwards, Alfonso B. Abizaid · 2016 · Neuroscience & Biobehavioral Reviews
  94. Prefrontal endocannabinoids, stress controllability and resilience: A hypothesis
    Nicholas B. Worley, Matthew N. Hill, John P. Christianson · 2017 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  95. Interactions Between Alcohol and the Endocannabinoid System
    George Kunos · 2020 · Alcoholism Clinical and Experimental Research
  96. Regional distribution and effects of postmortal delay on endocannabinoid content of the human brain
    Miklós Palkovits, Judy Harvey-White, J. Liu, Zsolt Kovács, Mátyás Bobest, Gábor Lovas, Attila György Bagó, George Kunos · 2008 · Neuroscience
  97. Endocannabinoid Signaling Directs Periimplantation Events
    Haibin Wang, Huirong Xie, Sudhansu K. Dey · 2006 · The AAPS Journal
  98. Functional lipidomics. Calcium-independent activation of endocannabinoid/endovanilloid lipid signalling in sensory neurons by protein kinases C and A and thrombin
    Vittorio Vellani, Stefania Petrosino, Luciano De PETROCELLIS, Marta Valenti, Massimiliano Prandini, Pier Cosimo Magherini, Peter Anthony McNaughton, Vincenzo Di Marzo · 2008 · Neuropharmacology
  99. Inhibition of C6 glioma cell proliferation by anandamide, 1-arachidonoylglycerol, and by a water soluble phosphate ester of anandamide: variability in response and involvement of arachidonic acid
    Christopher John Fowler, Kent‐Olov Jonsson, Anna Andersson, Juha Juntunen, Tomi Järvinen, Séverine Vandevoorde, Didier M. Lambert, Jeffrey C. Jerman, Darren Smart · 2003 · Biochemical Pharmacology
  100. Formation ofN‐acyl‐phosphatidylethanolamine andN‐acylethanolamine (including anandamide) during glutamate‐induced neurotoxicity
    Harald Severin Hansen, Birthe Moesgaard, Henrik Helmer Hansen, Arne Schousboe, Gitte Petersen · 1999 · Lipids